Computer aided selection of candidate vaccine antigens

Immunome Research

Volumn 6, Issue SUPPL. 2, 2010, Pages

  Flower, Darren R ^a,b   MacDonald, Isabel K ^b,c   Ramakrishnan, Kamna ^b,d   Davies, Matthew N ^e   Doytchinova, Irini A ^f  

^a ASTON UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BACTERIAL VACCINE; BCG VACCINE; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN; NEISSERIA MENINGITIDIS VACCINE; ORAL POLIOMYELITIS VACCINE; PNEUMOCOCCUS VACCINE; SUBUNIT VACCINE; UNCLASSIFIED DRUG; VACCINE; VIRULENCE FACTOR;

COMPUTER AIDED DESIGN; HUMAN; IMMUNOGENICITY; INFORMATION SCIENCE; NONHUMAN; PROTEIN ANALYSIS; REVIEW;

EID: 78149297469     PISSN: None     EISSN: 17457580     Source Type: Journal    
DOI: 10.1186/1745-7580-6-S2-S1     Document Type: Review

References (116)

1. Computer-aided biotechnology: from immuno-informatics to reverse vaccinology. S Vivona JL Gardy S Ramachandran FSL Brinkman GPS Raghava DR Flower F Filippini, Trends Biotechnol 2008 26 190 200 10.1016/j.tibtech.2007.12.006 18291542
2. D Flower, Bioinformatics for Vaccinology Wiley 1 2008
3. DR Flower MN Davies S Ranganathan, Bioinformatics for Immunomics Springer 1 2010
4. New vaccines against tuberculosis. PH Lambert T Hawkridge WA Hanekom, Clin Chest Med 2009 30 811 826 x 10.1016/j.ccm.2009.08.014 19925969
5. Computer-aided biotechnology: from immuno-informatics to reverse vaccinology. S Vivona JL Gardy S Ramachandran FS Brinkman GP Raghava DR Flower F Filippini, Trends Biotechnol 2008 26 190 200 10.1016/j.tibtech.2007.12.006 18291542
6. Harnessing bioinformatics to discover new vaccines. MN Davies DR Flower, Drug Discov Today 2007 12 389 395 10.1016/j.drudis.2007.03.010 17467575
7. The use of genomics in microbial vaccine development. S Bambini R Rappuoli, Drug Discov Today 2009 14 252 260 10.1016/j.drudis.2008.12.007 19150507
8. Post-genomic vaccine development. D Serruto R Rappuoli, Febs Lett 2006 580 2985 2992 10.1016/j.febslet.2006.04.084 16716781
9. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. M Mora C Donati D Medini A Covacci R Rappuoli, Curr Opin Microbiol 2006 9 532 536 10.1016/j.mib.2006.07.003 16890009
10. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens. D Serruto J Adu-Bobie B Capecchi R Rappuoli M Pizza V Masignani, J Biotechnol 2004 113 15 32 10.1016/j.jbiotec.2004.03.024 15380644
11. Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. H Tettelin NJ Saunders J Heidelberg AC Jeffries KE Nelson JA Eisen KA Ketchum DW Hood JF Peden RJ Dodson,, et al. Science 2000 287 1809 1815 10.1126/science.287.5459.1809 10710307
12. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. M Pizza V Scarlato V Masignani MM Giuliani B Arico M Comanducci GT Jennings L Baldi E Bartolini B Capecchi,, et al. Science 2000 287 1816 1820 10.1126/science.287.5459.1816 10710308
13. Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection. TM Wizemann JH Heinrichs JE Adamou AL Erwin C Kunsch GH Choi SC Barash CA Rosen HR Masure E Tuomanen,, et al. Infect Immun 2001 69 1593 1598 10.1128/IAI.69.3.1593-1598.2001 11179332
14. Identification of a universal Group B streptococcus vaccine by multiple genome screen. D Maione I Margarit CD Rinaudo V Masignani M Mora M Scarselli H Tettelin C Brettoni ET Iacobini R Rosini,, et al. Science 2005 309 148 150 10.1126/science.1109869 15994562
15. Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis. BC Ross L Czajkowski D Hocking M Margetts E Webb L Rothel M Patterson C Agius S Camuglia E Reynolds,, et al. Vaccine 2001 19 4135 4142 10.1016/S0264-410X(01)00173-6 11457538
16. Prediction of MHC-peptide binding: a systematic and comprehensive overview. EM Lafuente PA Reche, Curr Pharm Des 2009 15 3209 3220 10.2174/138161209789105162 19860671
17. In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion. U Gowthaman JN Agrewala, J Proteome Res 2008 7 154 163 10.1021/pr070527b 18034454
18. On evaluating MHC-II binding peptide prediction methods. Y El-Manzalawy D Dobbs V Honavar, Plos One 2008 3 3268 10.1371/journal.pone.0003268 18813344
19. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. HH Lin GL Zhang S Tongchusak EL Reinherz V Brusic, Bmc Bioinformatics 2008 9 Suppl 12 22 10.1186/1471-2105-9-S12-S22 19091022
20. A critical cross-validation of high throughput structural binding prediction methods for pMHC. B Knapp U Omasits S Frantal W Schreiner, J Comput Aided Mol Des 2009 23 301 307 10.1007/s10822-009-9259-2 19194661
21. Limitations of Ab initio predictions of peptide binding to MHC class II molecules. H Zhang P Wang N Papangelopoulos Y Xu A Sette PE Bourne O Lund J Ponomarenko M Nielsen B Peters, Plos One 2010 5 9272 10.1371/journal.pone. 0009272 20174654
22. Antibody-protein interactions: benchmark datasets and prediction tools evaluation. JV Ponomarenko PE Bourne, Bmc Struct Biol 2007 7 64 10.1186/1472-6807-7-64 17910770
23. Benchmarking B cell epitope prediction: underperformance of existing methods. MJ Blythe DR Flower, Protein Sci 2005 14 246 248 10.1110/ps.041059505 15576553
24. The immune epitope database 2.0. R Vita L Zarebski JA Greenbaum H Emami I Hoof N Salimi R Damle A Sette B Peters, Nucleic Acids Res 2010 38 854 862 10.1093/nar/gkp1004 19906713
25. The curation guidelines of the immune epitope database and analysis resource. R Vita B Peters A Sette, Cytometry A 2008 73 1066 1070 18688821
26. Immune epitope database analysis resource (IEDB-AR). Q Zhang P Wang Y Kim P Haste-Andersen J Beaver PE Bourne HH Bui S Buus S Frankild J Greenbaum,, et al. Nucleic Acids Res 2008 36 513 518 10.1093/nar/gkn254 18515843
27. The immune epitope database and analysis resource: from vision to blueprint. A Sette, Genome Inform 2004 15 299 16312048
28. The design and implementation of the immune epitope database and analysis resource. B Peters J Sidney P Bourne HH Bui S Buus G Doh W Fleri M Kronenberg R Kubo O Lund,, et al. Immunogenetics 2005 57 326 336 10.1007/s00251-005-0803-5 15895191 (Pubitemid 40905051)
29. The immune epitope database and analysis resource: from vision to blueprint. B Peters J Sidney P Bourne HH Bui S Buus G Doh W Fleri M Kronenberg R Kubo O Lund,, et al. PLoS Biol 2005 3 91 10.1371/journal.pbio.0030091 15760272
30. T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide. FE Tynan SR Burrows AM Buckle CS Clements NA Borg JJ Miles T Beddoe JC Whisstock MC Wilce SL Silins,, et al. Nat Immunol 2005 6 1114 1122 10.1038/ni1257 16186824
31. High resolution structures of highly bulged viral epitopes bound to major histocompatibility complex class I. Implications for T-cell receptor engagement and T-cell immunodominance. FE Tynan NA Borg JJ Miles T Beddoe D El-Hassen SL Silins WJ van Zuylen AW Purcell L Kjer-Nielsen J McCluskey,, et al. J Biol Chem 2005 280 23900 23909 10.1074/jbc.M503060200 15849183
32. Have we cut ourselves too short in mapping CTL epitopes? SR Burrows J Rossjohn J McCluskey, Trends Immunol 2006 27 11 16 10.1016/j.it.2005.11.001 16297661
33. A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design. LM Ebert YC Liu CS Clements NC Robson HM Jackson JL Markby N Dimopoulos BS Tan IF Luescher ID Davis,, et al. Cancer Res 2009 69 1046 1054 10.1158/0008-5472.CAN-08-2926 19176376
34. Proteins accessible to immune surveillance show significant T-cell epitope depletion: Implications for vaccine design. M Halling-Brown R Shaban D Frampton CE Sansom M Davies D Flower M Duffield RW Titball V Brusic DS Moss, Mol Immunol 2009 46 2699 2705 10.1016/j.molimm.2009.05.027 19560824
35. Are bacterial vaccine antigens T-cell epitope depleted? M Halling-Brown CE Sansom M Davies RW Titball DS Moss, Trends Immunol 2008 29 374 379 10.1016/j.it.2008.06.001 18603471
36. The ProDom database of protein domain families: more emphasis on 3D. C Bru E Courcelle S Carrere Y Beausse S Dalmar D Kahn, Nucleic Acids Res 2005 33 212 215 10.1093/nar/gki034 15608179
37. The Pfam protein families database. RD Finn J Mistry J Tate P Coggill A Heger JE Pollington OL Gavin P Gunasekaran G Ceric K Forslund,, et al. Nucleic Acids Res 2010 38 211 222 10.1093/nar/gkp985 19920124
38. PROSITE, a protein domain database for functional characterization and annotation. CJ Sigrist L Cerutti E de Castro PS Langendijk-Genevaux V Bulliard A Bairoch N Hulo, Nucleic Acids Res 2010 38 161 166 10.1093/nar/gkp885 19858104
39. Single proteins might have dual but related functions in intracellular and extracellular microenvironments. DC Radisky M Stallings-Mann Y Hirai MJ Bissell, Nat Rev Mol Cell Biol 2009 10 228 234 10.1038/nrm2633 19190671
40. Locating proteins in the cell using TargetP, SignalP and related tools. O Emanuelsson S Brunak G von Heijne H Nielsen, Nat Protoc 2007 2 953 971 10.1038/nprot.2007.131 17446895
41. Improved prediction of signal peptides: SignalP 3.0. JD Bendtsen H Nielsen G von Heijne S Brunak, J Mol Biol 2004 340 783 795 10.1016/j.jmb.2004. 05.028 15223320
42. A comprehensive assessment of N-terminal signal peptides prediction methods. KH Choo TW Tan S Ranganathan, Bmc Bioinformatics 2009 10 Suppl 15 2 10.1186/1471-2105-10-S15-S2 19958512
43. WoLF PSORT: protein localization predictor. P Horton KJ Park T Obayashi N Fujita H Harada CJ Adams-Collier K Nakai, Nucleic Acids Res 2007 35 585 587 10.1093/nar/gkm259 17517783
44. Secreted protein prediction system combining CJ-SPHMM, TMHMM, and PSORT. Y Chen P Yu J Luo Y Jiang, Mamm Genome 2003 14 859 865 10.1007/s00335-003-2296-6 14724739
45. PSORT-B: Improving protein subcellular localization prediction for Gram-negative bacteria. JL Gardy C Spencer K Wang M Ester GE Tusnady I Simon S Hua K deFays C Lambert K Nakai FS Brinkman, Nucleic Acids Res 2003 31 3613 3617 10.1093/nar/gkg602 12824378
46. PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. K Nakai P Horton, Trends Biochem Sci 1999 24 34 36 10.1016/S0968-0004(98)01336-X 10087920
47. Predicting protein subcellular locations using hierarchical ensemble of Bayesian classifiers based on Markov chains. A Bulashevska R Eils, Bmc Bioinformatics 2006 7 298 10.1186/1471-2105-7-298 16774677
48. SubLoc: a server/client suite for protein subcellular location based on SOAP. H Chen N Huang Z Sun, Bioinformatics 2006 22 376 377 10.1093/ bioinformatics/bti822 16339283
49. Gpos-PLoc: an ensemble classifier for predicting subcellular localization of Gram-positive bacterial proteins. HB Shen KC Chou, Protein Eng Des Sel 2007 20 39 46 10.1093/protein/gzl053 17244638
50. Prediction of twin-arginine signal peptides. JD Bendtsen H Nielsen D Widdick T Palmer S Brunak, Bmc Bioinformatics 2005 6 167 10.1186/1471-2105-6-167 15992409
51. Prediction of lipoprotein signal peptides in Gram-negative bacteria. AS Juncker H Willenbrock G Von Heijne S Brunak H Nielsen A Krogh, Protein Sci 2003 12 1652 1662 10.1110/ps.0303703 12876315
52. Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server. L Kall A Krogh EL Sonnhammer, Nucleic Acids Res 2007 35 429 432 10.1093/nar/gkm256 17483518
53. Validating subcellular localization prediction tools with mycobacterial proteins. D Restrepo-Montoya C Vizcaino LF Nino M Ocampo ME Patarroyo MA Patarroyo, Bmc Bioinformatics 2009 10 134 10.1186/1471-2105-10-134 19422713
54. Toward bacterial protein sub-cellular location prediction: single-class discrimminant models for all gram- and gram+ compartments. PD Taylor TK Attwood DR Flower, Bioinformation 2006 1 276 280 17597907
55. Multi-class subcellular location prediction for bacterial proteins. PD Taylor TK Attwood DR Flower, Bioinformation 2006 1 260 264 17597904
56. Alpha helical trans-membrane proteins: Enhanced prediction using a Bayesian approach. PD Taylor CP Toseland TK Attwood DR Flower, Bioinformation 2006 1 234 236 17597896
57. Beta barrel trans-membrane proteins: Enhanced prediction using a Bayesian approach. PD Taylor CP Toseland TK Attwood DR Flower, Bioinformation 2006 1 231 233 17597895
58. A predictor of membrane class: Discriminating alpha-helical and beta-barrel membrane proteins from non-membranous proteins. PD Taylor CP Toseland TK Attwood DR Flower, Bioinformation 2006 1 208 213 17597890
59. TATPred: a Bayesian method for the identification of twin arginine translocation pathway signal sequences. PD Taylor CP Toseland TK Attwood DR Flower, Bioinformation 2006 1 184 187 17597885
60. LIPPRED: A web server for accurate prediction of lipoprotein signal sequences and cleavage sites. PD Taylor CP Toseland TK Attwood DR Flower, Bioinformation 2006 1 176 179 17597883
61. Combining algorithms to predict bacterial protein sub-cellular location: Parallel versus concurrent implementations. PD Taylor TK Attwood DR Flower, Bioinformation 2006 1 285 289 17597909
62. DBSubLoc: database of protein subcellular localization. T Guo S Hua X Ji Z Sun, Nucleic Acids Res 2004 32 122 124 10.1093/nar/gkh109 14681374
63. Predicting the subcellular localization of viral proteins within a mammalian host cell. MS Scott R Oomen DY Thomas MT Hallett, Virol J 2006 3 24 10.1186/1743-422X-3-24 16595001
64. Virus-PLoc: a fusion classifier for predicting the subcellular localization of viral proteins within host and virus-infected cells. HB Shen KC Chou, Biopolymers 2007 85 233 240 10.1002/bip.20640 17120237
65. SYFPEITHI: database for searching and T-cell epitope prediction. MM Schuler MD Nastke S Stevanovikc, Methods Mol Biol 2007 409 75 93 full-text 18449993
66. SYFPEITHI: database for MHC ligands and peptide motifs. H Rammensee J Bachmann NP Emmerich OA Bachor S Stevanovic, Immunogenetics 1999 50 213 219 10.1007/s002510050595 10602881
67. HIV sequence databases. C Kuiken B Korber RW Shafer, AIDS Rev 2003 5 52 61 12875108
68. MHCBN 4.0: A database of MHC/TAP binding peptides and T-cell epitopes. S Lata M Bhasin GP Raghava, BMC Res Notes 2009 2 61 10.1186/1756-0500-2-61 19379493
69. MHCBN: a comprehensive database of MHC binding and non-binding peptides. M Bhasin H Singh GP Raghava, Bioinformatics 2003 19 665 666 10.1093/ bioinformatics/btg055 12651731
70. EPIMHC: a curated database of MHC-binding peptides for customized computational vaccinology. PA Reche H Zhang JP Glutting EL Reinherz, Bioinformatics 2005 21 2140 2141 10.1093/bioinformatics/bti269 15657103
71. AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data. CP Toseland DJ Clayton H McSparron SL Hemsley MJ Blythe K Paine IA Doytchinova P Guan CK Hattotuwagama DR Flower, Immunome Res 2005 1 4 10.1186/1745-7580-1-4 16305757
72. JenPep: a novel computational information resource for immunobiology and vaccinology. H McSparron MJ Blythe C Zygouri IA Doytchinova DR Flower, J Chem Inf Comput Sci 2003 43 1276 1287 12870921
73. JenPep: a database of quantitative functional peptide data for immunology. MJ Blythe IA Doytchinova DR Flower, Bioinformatics 2002 18 434 439 10.1093/bioinformatics/18.3.434 11934742
74. Bacterial virulence: can we draw the line? TM Wassenaar W Gaastra, FEMS Microbiol Lett 2001 201 1 7 10.1111/j.1574-6968.2001.tb10724.x 11445159
75. VFDB 2008 release: an enhanced web-based resource for comparative pathogenomics. J Yang L Chen L Sun J Yu Q Jin, Nucleic Acids Res 2008 36 539 542 10.1093/nar/gkm951 17984080
76. VFDB: a reference database for bacterial virulence factors. L Chen J Yang J Yu Z Yao L Sun Y Shen Q Jin, Nucleic Acids Res 2005 33 325 328 10.1093/nar/gki008 15608208
77. CandiVF - Candida albicans virulence factor database. S Tongchusak SC Chaiyaroj A Veeramani JLY Koh V Brusic, Int J Pept Res Ther 2005 11 271 277 10.1007/s10989-005-9268-5 (Pubitemid 41772366)
78. PHI-base: a new database for pathogen host interactions. R Winnenburg TK Baldwin M Urban C Rawlings J Kohler KE Hammond-Kosack, Nucleic Acids Res 2006 34 459 D464 10.1093/nar/gkj047 16381911
79. AntigenDB: an immunoinformatics database of pathogen antigens. HR Ansari DR Flower GPS Raghava, Nucleic Acids Res 2010 38 847 D853 10.1093/nar/gkp830 19820110
80. The lipocalin protein family: Structure and function. DR Flower, Biochem J 1996 318 1 14 8761444
81. Structure and Sequence Relationships in the Lipocalins and Related Proteins. DR Flower ACT North TK Attwood, Protein Sci 1993 2 753 761 10.1002/pro.5560020507 7684291
82. The lipocalin protein family: structural and sequence overview. DR Flower AC North CE Sansom, Biochim Biophys Acta 2000 1482 9 24 11058743
83. Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects. D Kanduc, Expert Opin Biol Ther 2009 9 45 53 10.1517/14712590802614041 19063692
84. Peptimmunology: immunogenic peptides and sequence redundancy. D Kanduc, Curr Drug Discov Technol 2005 2 239 244 10.2174/157016305775202946 16475920
85. Primer: mechanisms of immunologic tolerance. NJ Singh RH Schwartz, Nat Clin Pract Rheumatol 2006 2 44 52 10.1038/ncprheum0049 16932651
86. Recent advances in immune modulation. CH Miao, Curr Gene Ther 2007 7 391 402 10.2174/156652307782151524 17979685
87. Cutting edge: contributions of apoptosis and anergy to systemic T cell tolerance. L Barron B Knoechel J Lohr AK Abbas, J Immunol 2008 180 2762 2766 18292495
88. A computational approach for identifying pathogenicity islands in prokaryotic genomes. SH Yoon CG Hur HY Kang YH Kim TK Oh JF Kim, Bmc Bioinformatics 2005 6 184 10.1186/1471-2105-6-184 16033657
89. Identification and characterization of pathogenicity and other genomic islands using base composition analyses. L Guy, Future Microbiol 2006 1 309 316 10.2217/17460913.1.3.309 17661643
90. Identification and characterization of specific sequences encoding pathogenicity associated proteins in the genome of commensal Neisseria species. K Wolff A Stern, FEMS Microbiol Lett 1995 125 255 263 10.1111/j.1574-6968.1995. tb07366.x 7875573
91. Prediction of pathogenicity islands in enterohemorrhagic Escherichia coli O157:H7 using genomic barcodes. G Wang F Zhou V Olman F Li Y Xu, Febs Lett 2010 584 194 198 10.1016/j.febslet.2009.11.067 19941858
92. CpGcluster: a distance-based algorithm for CpG-island detection. M Hackenberg C Previti PL Luque-Escamilla P Carpena J Martinez-Aroza JL Oliver, Bmc Bioinformatics 2006 7 446 10.1186/1471-2105-7-446 17038168
93. CpGIF: an algorithm for the identification of CpG islands. Y Sujuan A Asaithambi Y Liu, Bioinformation 2008 2 335 338 18685720
94. Identifying CpG Islands by Different Computational Techniques. B Hutter M Paulsen V Helms, OMICS 2009 19196100
95. CpG-MI: a novel approach for identifying functional CpG islands in mammalian genomes. J Su Y Zhang J Lv H Liu X Tang F Wang Y Qi Y Feng X Li, Nucleic Acids Res 2010 38 6 10.1093/nar/gkp882 19854943
96. Structure and sequence relationships in the lipocalins and related proteins. DR Flower AC North TK Attwood, Protein Sci 1993 2 753 761 10.1002/pro.5560020507 7684291
97. Structural Relationship of Streptavidin to the Calycin Protein Superfamily. DR Flower, Febs Lett 1993 333 99 102 10.1016/0014-5793(93)80382-5 8224179
98. VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. IA Doytchinova DR Flower, Bmc Bioinformatics 2007 8 10.1186/1471-2105-8-4 17207271
99. Identifying candidate subunit vaccines using an alignment-independent method based on principal amino acid properties. IA Doytchinova DR Flower, Vaccine 2007 25 856 866 10.1016/j.vaccine.2006.09.032 17045707
100. DNA and Peptide Sequences and Chemical Processes Multivariately Modeled by Principal Component Analysis and Partial Least-Squares Projections to Latent Structures. S Wold J Jonsson M Sjostrom M Sandberg S Rannar, Anal Chim Acta 1993 277 239 253 10.1016/0003-2670(93)80437-P (Pubitemid 23158002)
101. Principal Property-Values for 6 Nonnatural Amino-Acids and Their Application to a Structure Activity Relationship for Oxytocin Peptide Analogs. S Wold L Eriksson S Hellberg J Jonsson M Sjostrom B Skagerberg C Wikstrom, Can J Chem 1987 65 1814 1820 10.1139/v87-305
102. Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis. I Dimitrov P Garnev DR Flower I Doytchinova, Eur J Med Chem 2010 45 236 243 10.1016/j.ejmech.2009.09.049 19896246
103. Proteochemometrics mapping of the interaction space for retroviral proteases and their substrates. A Kontijevskis R Petrovska S Yahorava J Komorowski JE Wikberg, Bioorg Med Chem 2009 17 5229 5237 10.1016/j.bmc.2009.05. 045 19539482
104. Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases. P Prusis M Lapins S Yahorava R Petrovska P Niyomrattanakit G Katzenmeier JE Wikberg, Bioorg Med Chem 2008 16 9369 9377 10.1016/j.bmc.2008.08. 081 18824362
105. Generalized modeling of enzyme-ligand interactions using proteochemometrics and local protein substructures. H Strombergsson A Kryshtafovych P Prusis K Fidelis JE Wikberg J Komorowski TR Hvidsten, Proteins 2006 65 568 579 10.1002/prot.21163 16948162
106. Rough set-based proteochemometrics modeling of G-protein-coupled receptor-ligand interactions. H Strombergsson P Prusis H Midelfart M Lapinsh JE Wikberg J Komorowski, Proteins 2006 63 24 34 10.1002/prot.20777 16435365
107. Improved approach for proteochemometrics modeling: application to organic compound - amine G protein-coupled receptor interactions. M Lapinsh P Prusis S Uhlen JE Wikberg, Bioinformatics 2005 21 4289 4296 10.1093/bioinformatics/bti703 16204343
108. Melanocortin receptors: ligands and proteochemometrics modeling. JE Wikberg F Mutulis I Mutule S Veiksina M Lapinsh R Petrovska P Prusis, Ann N Y Acad Sci 2003 994 21 26 10.1111/j.1749-6632.2003.tb03158.x 12851294
109. Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. M Lapinsh P Prusis T Lundstedt JE Wikberg, Mol Pharmacol 2002 61 1465 1475 10.1124/mol.61.6.1465 12021408
110. Peptide Quantitative Structure-Activity-Relationships, a Multivariate Approach. S Hellberg M Sjostrom B Skagerberg S Wold, J Med Chem 1987 30 1126 1135 10.1021/jm00390a003 3599020
111. Multivariate Parametrization of 55 Coded and Non-Coded Amino-Acids. J Jonsson L Eriksson S Hellberg M Sjostrom S Wold, Quant Struct-Act Rel 1989 8 204 209 10.1002/qsar.19890080303
112. New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. M Sandberg L Eriksson J Jonsson M Sjostrom S Wold, J Med Chem 1998 41 2481 2491 10.1021/jm9700575 9651153
113. Bioinformatic Approach for Identifying Parasite and Fungal Candidate Subunit Vaccines. IA Doytchinova DR Flower, The Open Vaccine Journal 2008 1 4 10.2174/1875035400801010022
114. NERVE: new enhanced reverse vaccinology environment. S Vivona F Bernante F Filippini, BMC Biotechnol 2006 6 35 10.1186/1472-6750-6-35 16848907
115. DyNAVacS: an integrative tool for optimized DNA vaccine design. N Harish R Gupta P Agarwal V Scaria B Pillai, Nucleic Acids Res 2006 34 264 266 10.1093/nar/gkl242 16845007
116. Enzymes, metabolites and fluxes. DA Fell, J Exp Bot 2005 56 267 272 10.1093/jxb/eri011 15545297